X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.expresspharma.in/basileas-zevtera-will-play-unique-yet-critical-role-in-mrsab-globaldata/
https://www.basilea.com/news/news/basilea-awarded-carb-x-grant-to-develop-recently-acquired-novel-class-of-antibiotics?type=1546938654
https://www.fda.gov/news-events/press-announcements/fda-approves-new-antibiotic-three-different-uses
https://www.globenewswire.com//news-release/2024/03/11/2843460/0/en/Continued-strong-Cresemba-isavuconazole-sales-performance-in-Asia-Pacific-and-China-triggers-milestone-payment-to-Basilea.html
https://www.globenewswire.com//news-release/2024/02/13/2827947/0/en/Basilea-reports-strong-2023-full-year-results-with-profitability-significantly-above-guidance-whilst-substantially-expanding-the-R-D-portfolio.html
https://www.globenewswire.com//news-release/2024/01/19/2812103/0/en/Cresemba-sales-in-Latin-America-trigger-first-sales-milestone-payment-to-Basilea.html
https://www.globenewswire.com//news-release/2024/01/15/2808936/0/en/Basilea-announces-acquisition-of-preclinical-antibiotics-program-from-Spexis.html
https://www.globenewswire.com//news-release/2024/01/05/2804449/0/en/Basilea-provides-portfolio-status-update.html
https://www.globenewswire.com//news-release/2023/12/20/2799014/0/en/Basilea-announces-accelerated-loan-repayment.html
https://www.globenewswire.com//news-release/2023/12/11/2793536/0/en/Basilea-announces-that-FDA-approves-expanded-use-of-antifungal-Cresemba-isavuconazole-in-the-United-States-in-children-with-invasive-aspergillosis-and-invasive-mucormycosis.html
Market Place
Share 
